Details of the Drug

General Information of Drug (ID: DMZB7A6)

• Drug Name: OG2023SC
• Synonyms: NNC0113-2023; NN9023

Indication

Disease Entry	ICD 11	Status	REF
Type 2 diabetes	5A11	Phase 1	[1]

• Cross-matching ID: TTD ID: D3KZ4Y

References

• [1] ClinicalTrials.gov (NCT03617081) First Research Study of the Possible New Medicine NNC0113-2023 in Healthy Men.. U.S. National Institutes of Health.